Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Liver transplantation with abo incompatible graft under immuoadsorption protocol – case report

H Ismail, M Markiewicz-Kijewska, P Kaliciński, J Teisseyre, A Chyżyńska, S Prokurat, I Sokolnicka

Ann Transplant 2009; 14(1): 40-41 :: ID: 880345


Background: ABO incompatible liver transplantation is still controversial, but
accepted in selected cases. Recently several authors reported the use of new
technology helping to eliminate and reduce post-transplant anti-donor ABO
specific hemagglutinin titters to assist immunosuppression in preventing acute rejection after transplantation. We report the case of a liver transplantation with ABO incompatible graft under immunoadsorption protocol.
Case Report: 17 year-old boy with acute decompensation of chronic liver failure due to PSC and AIH was qualified for urgent liver transplantation. After 3 following ABO incompatible donors we decided to perform liver transplantation across blood groups (donor: B, Rh positive; recipient A, Rh positive). Immunosuppressive protocol consisted of basiliximab, tacrolimus, mycophenolate mofetil and corticosteroids. Additionally 3 immunoadsorption sessions with ABO Glycorex type B on 3, 7, 12 postoperative days were performed. Anti-B isoagglutinin titter was 1:2048. Just after transplantation it dropped to 1:4 and increased again to 1:1024 on postoperative day 6 and then to 1:8192 on post operative day 10. After 3rd immunoadsorption the titter decreased to 1:64 on day 21. There was no acute rejection until he was discharged home and until now, 6 months after Tx. The liver function is excellent. The only problem observed after transplantation was mild anaemia due to the low grade haemolysis in the postoperative period.
Conclusions: Immunoadsorption therapy has been safely and effectively introduced in a patient with ABO incompatible donor liver transplantation.

Keywords: Liver Transplantation

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358